Gene · 64761
Papers1,639
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,639
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Causal splicing variants revealed by deep-learning integration of single-cell sQTL mapping under influenza infection. | Res Sq | 2026 | 41542048 | PubTator, text mining | PubMed |
| Functional characterization of short-isoform of PARP12 in the immune response to SVCV infection in common carp (Cyprinus carpio). | Dev Comp Immunol | 2026 | 41539453 | PubTator, text mining | PubMed |
| Pathway for the Development of ATR Inhibitors in Pediatric Malignancies: An ACCELERATE Multistakeholder Analysis. | JCO Precis Oncol | 2026 | 41538758 | PubTator, text mining | PubMed |
Phase II randomized study of first-line carboplatin and paclitaxel in combination with pembrolizumab, followed by maintenance pembrolizumab alone or with nesuparib, in mismatch-repair proficient, advanced or recurrent endometrial cancer (PENELOPE). | J Gynecol Oncol | 2026 | 41514313 | PubTator, text mining | PubMed |
| PARG regulates the proteasomal degradation of TARG1. | Cell Rep | 2026 | 41499238 | PubTator, text mining | PubMed |
| PARP1 and PARP2 are dispensable for DNA repair by microhomology-mediated end-joining at double-ended DSBs. | Nucleic Acids Res | 2026 | 41495903 | PubTator, text mining | PubMed |
| Learned Conformational Space and Pharmacophore Into Molecular Foundational Model. | Adv Sci (Weinh) | 2026 | 41486619 | PubTator, text mining | PubMed |
| Design and Development of DNA Damage Chemical Inducers of Proximity for Targeted Cancer Therapy. | J Am Chem Soc | 2026 | 41480895 | PubTator, text mining | PubMed |
| CD38 is a key mediator of NAD+ depletion in the brain of ZIKV-infected mice. | iScience | 2025 | 41362627 | PubTator, text mining | PubMed |
| Poly (ADP-ribose) polymerase (PARP) inhibitors approved for the treatment of cancer. | Pharmacol Res | 2025 | 41349848 | PubTator, text mining | PubMed |
| Design and Development of DNA Damage Chemical Inducers of Proximity (DD-CIP) for Targeted Cancer Therapy. | bioRxiv | 2025 | 41278667 | PubTator, text mining | PubMed |
| Abstracts of the Annual Conference of the German Society for Biological Radiation Research (DeGBS) : Munich, Germany. 29 September-1 October 2025. | Radiat Oncol | 2025 | 41254773 | PubTator, text mining | PubMed |
| Epigenetic modification of cuproptosis by non-coding RNAs in cancer drug resistance. | Mol Cancer | 2025 | 40999456 | PubTator, text mining | PubMed |
| JPI-547, a Dual Inhibitor of PARP/Tankyrase, Shows Antitumor Activity Against Pancreatic Cancers with Homologous Recombination Repair Deficiency or Wnt-Addiction. | Int J Biol Sci | 2025 | 40959288 | PubTator, text mining | PubMed |
| Design, development, and therapeutic applications of PARP-1 selective inhibitors. | Future Med Chem | 2025 | 40948328 | PubTator, text mining | PubMed |
| Deltex and RING-UIM E3 ligases cooperate to create a ubiquitin-ADP-ribose hybrid mark on tankyrase, promoting its stabilization. | Sci Adv | 2025 | 40901936 | PubTator, text mining | PubMed |
Routine Tumor Testing for Homologous Recombination Deficiency in Patients With High Grade Epithelial Ovarian Cancer at a Statewide Gynecological Cancer Service in Western Australia: An Observational Study. | Cancer Rep (Hoboken) | 2025 | 40891252 | PubTator, text mining | PubMed |
| N(6)-methyladenosine modification of ADGRA3 by ZC3H13 suppresses papillary thyroid cancer cell malignancy by inactivating the PI3K/Akt/mTOR signaling pathway. | Discov Oncol | 2025 | 40890321 | PubTator, text mining | PubMed |
| Synthetic Lethal Combinations of DNA Repair Inhibitors and Genotoxic Agents to Target High-Risk Diffuse Large B Cell Lymphoma. | Hematol Oncol | 2025 | 40847617 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Ferroptosis Markers in Lupus Nephritis Based on Bioinformatics Analysis and Experimental Validation. | J Inflamm Res | 2025 | 40823359 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64761/papers?page=3